Testosterone and exercise: effects on fitness, body composition, and strength in middle-to-older aged men with low-normal serum testosterone levels.

As men age, serum testosterone (T) concentrations decrease, as do fitness, strength, and lean mass. Whether testosterone treatment confers additive benefit to reverse these changes when combined with exercise training in middle-to-older aged men remains unclear. We assessed the effects of T treatment and exercise, alone and in combination, on aerobic capacity (V̇opeak), body composition, and muscular strength in men 50-70 yr, waist circumference ≥95 cm and low-normal serum T (6-14 nmol·L). Participants ( = 80) were randomized to AndroForte5 (testosterone 5.0% wt/vol, 100 mg/2 mL) cream (T), or matching placebo (P), applied transdermally daily, and supervised center-based exercise (Ex) or no additional exercise (NEx), for 12-wk. Exercise increased V̇o and strength versus nonexercise (V̇o: T + Ex: +2.5 mL·kg·min, P + Ex: +3.2 mL·kg·min, < 0.001; leg press: T + Ex: +31 kg, P + Ex: +24 kg, = 0.006). T treatment did not affect V̇o or strength. Exercise decreased total (T + Ex: -1.7, P + Ex: -2.3 kg, < 0.001) and visceral fat (T + Ex: -0.1 kg, P + Ex: -0.3 kg, = 0.003), and increased total (T + Ex: +1.4 kg, P + Ex: +0.7 kg, = 0.008) and arm lean mass (T + Ex: +0.5 kg, P + Ex: +0.3 kg, = 0.024). T treatment did not affect total or visceral fat, but increased total (T + Ex: +1.4 kg, T + NEx: +0.7 kg, = 0.015), leg (T + Ex: +0.3 kg, T + NEx: +0.2 kg, = 0.024), and arm lean mass (T + Ex: +0.5 kg, T + NEx: +0.2 kg, = 0.046). T + Ex increased arm lean mass (T + Ex: +0.5 kg vs. P + NEx: -0.0 kg, = 0.001) and leg strength (T + Ex: +31 kg vs. P + NEx: +12 kg, = 0.032) compared with P + NEx, with no other additive effects. Exercise training was more effective than T treatment in increasing aerobic capacity and decreasing total and visceral fat mass. T treatment at therapeutic doses increased lean mass but conferred limited additional benefit when combined with exercise. Exercise should be evaluated as an antiaging intervention in preference to testosterone treatment in men. We illustrate that exercise training generates superior outcomes to testosterone treatment for improving aerobic fitness, muscular strength, and total and visceral fat mass in men 50-70 yr with low-normal serum testosterone concentrations. Adding testosterone treatment to exercise did not provide any additive benefit for these variables. Testosterone treatment alone and exercise alone had similar impacts on lean mass. Therefore, men unable to exercise may obtain benefit from testosterone treatment alone to improve lean mass.